C

CareDx

CDNA

23.610
USD
3.68
(18.46%)
مفتوح الان
حجم التداول
18,158
الربح لكل سهم
0
العائد الربحي
0
P/E
-8
حجم السوق
1,238,335,388
أصول ذات صلة
E
EXAS
12.150
(26.55%)
57.910 USD
G
GH
-1.770
(-5.04%)
33.380 USD
H
HOLX
1.610
(1.97%)
83.220 USD
I
ILMN
-0.250
(-0.20%)
122.370 USD
M
MYGN
-0.390
(-1.39%)
27.580 USD
N
NVTA
0
(0%)
0.000000 USD
الأخبار المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.